首页> 外文期刊>Journal of Medical Radiation Sciences >Retrospective evaluation of dosimetric quality for prostate carcinomas treated with 3D conformal, intensity modulated and volumetric modulated arc radiotherapy
【24h】

Retrospective evaluation of dosimetric quality for prostate carcinomas treated with 3D conformal, intensity modulated and volumetric modulated arc radiotherapy

机译:回顾性评估3D保形,强度调制和容积调制弧线放射治疗的前列腺癌的剂量质量

获取原文
           

摘要

AbstractIntroductionThis study examines and compares the dosimetric quality of radiotherapy treatment plans for prostate carcinoma across a cohort of 163 patients treated across five centres: 83 treated with three-dimensional conformal radiotherapy (3DCRT), 33 treated with intensity modulated radiotherapy (IMRT) and 47 treated with volumetric modulated arc therapy (VMAT).MethodsTreatment plan quality was evaluated in terms of target dose homogeneity and organs at risk (OAR), through the use of a set of dose metrics. These included the mean, maximum and minimum doses; the homogeneity and conformity indices for the target volumes; and a selection of dose coverage values that were relevant to each OAR. Statistical significance was evaluated using two-tailed Welch's T-tests. The Monte Carlo DICOM ToolKit software was adapted to permit the evaluation of dose metrics from DICOM data exported from a commercial radiotherapy treatment planning system.ResultsThe 3DCRT treatment plans offered greater planning target volume dose homogeneity than the other two treatment modalities. The IMRT and VMAT plans offered greater dose reduction in the OAR: with increased compliance with recommended OAR dose constraints, compared to conventional 3DCRT treatments. When compared to each other, IMRT and VMAT did not provide significantly different treatment plan quality for like-sized tumour volumes.ConclusionsThis study indicates that IMRT and VMAT have provided similar dosimetric quality, which is superior to the dosimetric quality achieved with 3DCRT.
机译:摘要简介本研究检查并比较了五个中心的163名患者的队列研究中前列腺癌放射治疗计划的剂量学质量:83名接受三维适形放疗(3DCRT),33名接受调强放疗(IMRT)和47名方法采用一组剂量指标,根据目标剂量的均一性和处于危险状态的器官(OAR)评估治疗计划的质量。这些包括平均,最大和最小剂量;目标体积的均一性和合格指数;以及与每个OAR相关的剂量覆盖率值的选择。使用两尾韦尔奇T检验评估统计学显着性。修改了Monte Carlo DICOM ToolKit软件后,可以根据从商业放射疗法治疗计划系统导出的DICOM数据评估剂量指标。结果3DCRT治疗计划提供了比其他两种治疗方式更大的计划目标体积剂量均一性。 IMRT和VMAT计划提供了更大的OAR剂量减少:与传统的3DCRT治疗相比,对建议的OAR剂量限制的依从性更高。当相互比较时,IMRT和VMAT并未提供相同大小肿瘤体积的治疗计划质量。结论本研究表明IMRT和VMAT提供了相似的剂量质量,优于3DCRT达到的剂量质量。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号